Sort   by:  
 Page size 
UnknownCardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial.
Not available
S-EPMC10044361 | biostudies-literature
UnknownAlpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer.
Not available
S-EPMC8595766 | biostudies-literature
UnknownUpdated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Not available
S-EPMC8103014 | biostudies-literature
UnknownAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Not available
S-EPMC5538020 | biostudies-literature
Sort   by:  
 Page size